These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18453023)

  • 1. Assessing the impact of FDG-PET in the management of anal cancer.
    Nguyen BT; Joon DL; Khoo V; Quong G; Chao M; Wada M; Joon ML; See A; Feigen M; Rykers K; Kai C; Zupan E; Scott A
    Radiother Oncol; 2008 Jun; 87(3):376-82. PubMed ID: 18453023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of positron emission tomography-computed tomography in the management of anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
    Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
    Jones M; Hruby G; Solomon M; Rutherford N; Martin J
    Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M; Smith RB; Graham MM; Hoffman HT; Tan H; Funk GF; Graham SM; Chang K; Dornfeld KJ; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):991-9. PubMed ID: 16099601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review.
    Piperkova E; Raphael B; Altinyay M; Castellon I; Libes R; Sandella N; Abdel-Dayem H
    J BUON; 2006; 11(4):523-7. PubMed ID: 17309188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
    Saboo SS; Zukotynski K; Shinagare AB; Krajewski KM; Ramaiya N
    Abdom Imaging; 2013 Aug; 38(4):728-35. PubMed ID: 23011550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma.
    Iagaru A; Kundu R; Jadvar H; Nagle D
    Hell J Nucl Med; 2009; 12(1):26-9. PubMed ID: 19330178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.
    Teagle AR; Gilbert DC; Jones JR; Burkill GJ; McKinna F; Dizdarevic S
    Nucl Med Commun; 2016 Oct; 37(10):1038-45. PubMed ID: 27341410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
    Nguyen BD; Ram PC; Roarke MC
    Clin Nucl Med; 2007 Mar; 32(3):234-6. PubMed ID: 17314608
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.
    Winton Ed; Heriot AG; Ng M; Hicks RJ; Hogg A; Milner A; Leong T; Fay M; MacKay J; Drummond E; Ngan SY
    Br J Cancer; 2009 Mar; 100(5):693-700. PubMed ID: 19259091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
    Schwarz JK; Siegel BA; Dehdashti F; Myerson RJ; Fleshman JW; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):180-6. PubMed ID: 17996387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma.
    Goldman KE; White EC; Rao AR; Kaptein JS; Lien WW
    Pract Radiat Oncol; 2016; 6(5):e149-e154. PubMed ID: 26948134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
    Day FL; Link E; Ngan S; Leong T; Moodie K; Lynch C; Michael M; Winton Ed; Hogg A; Hicks RJ; Heriot A
    Br J Cancer; 2011 Aug; 105(4):498-504. PubMed ID: 21792197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients.
    Slim N; Passoni P; Incerti E; Tummineri R; Gumina C; Cattaneo GM; De Nardi P; Canevari C; Fiorino C; Ronzoni M; Tamburini AM; Burgio V; Gianolli L; Di Muzio N
    Sci Rep; 2020 Sep; 10(1):14613. PubMed ID: 32884036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.